Terms ending in 2037
Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,251,904 | Methods for Treating Arenaviridae and Coronaviridae Virus Infections In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 10,183,951 | Solid Forms of a Thienopyrimidinedione Acc Inhibitor and Methods for Production Thereof In force · High confidence | Gilead Apollo, LLC | In force | High confidence | |
| US 10,487,090 | Solid Forms of a Thienopyrimidinedione Acc Inhibitor and Methods for Production Thereof In force · High confidence | Gilead Apollo, Inc. | In force | High confidence | |
| US 11,912,718 | Solid Forms of a Thienopyrimidinedione Acc Inhibitor and Methods for Production Thereof In force · High confidence | Gilead Apollo, LLC | In force | High confidence | |
| US 11,905,299 | Cot Modulators and Methods of Use Thereof In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 10,307,438 | Methods of Treating Hepatitis E Viral Infection In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 10,912,814 | Combination Formulation of Three Antiviral Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 11,338,007 | Combination Formulation of Three Antiviral Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 10,421,730 | FXR (NR1H4) Modulating Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 10,774,054 | FXR (NR1H4) Modulating Compounds In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| 35 more term ends in 2037 · Pro | |||||
10 of 45 patents shown. Soonest term end first, then patent number.
Pro members see all 45.
40 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.